Improved metabolic control decreases platelet activation markers in patients with type-2 diabetes.
| Autor: | Eibl, N.1, Krugluger, W.1, Streit, G.1, Schrattbauer, K.1, Hopmeier, P.1, Schernthaner, G.1 guntram.schernthaner@kar.magwien.gv.at |
|---|---|
| Zdroj: | European Journal of Clinical Investigation. Mar2004, Vol. 34 Issue 3, p205-209. 5p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|